Published in Neurobiol Aging on October 11, 2012
Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther (2014) 0.93
fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. Neuroimage Clin (2014) 0.92
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study. PLoS One (2014) 0.88
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. Cereb Cortex (2014) 0.83
Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies. Int Psychogeriatr (2013) 0.82
Altered Functional Connectivity in Essential Tremor: A Resting-State fMRI Study. Medicine (Baltimore) (2015) 0.82
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. J Neurol (2013) 0.79
Simultaneous EEG and fMRI: towards the characterization of structure and dynamics of brain networks. Dialogues Clin Neurosci (2013) 0.78
Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences. Int J Geriatr Psychiatry (2015) 0.77
Clinical utility of resting-state functional connectivity magnetic resonance imaging for mood and cognitive disorders. J Neural Transm (Vienna) (2017) 0.76
Medio-dorsal thalamus and confabulations: Evidence from a clinical case and combined MRI/DTI study. Neuroimage Clin (2016) 0.75
Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease. Hum Brain Mapp (2015) 0.75
Structural Connectivity is Differently Altered in Dementia with Lewy Body and Alzheimer's Disease. Front Aging Neurosci (2015) 0.75
Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features. J Neural Transm (Vienna) (2017) 0.75
Psychosis in parkinsonism: an unorthodox approach. Neuropsychiatr Dis Treat (2017) 0.75
Independent component analysis of fMRI group studies by self-organizing clustering. Neuroimage (2005) 2.33
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule. Int J Geriatr Psychiatry (2007) 1.92
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol (2011) 1.83
Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol (2010) 1.79
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease. Mov Disord (2014) 1.76
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat Cell Biol (2011) 1.76
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet (2006) 1.56
Paradoxical kinesia in parkinsonian patients surviving earthquake. Mov Disord (2010) 1.53
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting. Eur J Radiol (2011) 1.52
LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise. BMC Bioinformatics (2007) 1.44
Macrostructural alterations of subcortical grey matter in psychogenic erectile dysfunction. PLoS One (2012) 1.44
Dynamics of male sexual arousal: distinct components of brain activation revealed by fMRI. Neuroimage (2005) 1.44
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Neurology (2003) 1.38
Comment on "is fetal magnetic resonance imaging indicated when ultrasound isolated mild ventriculomegaly is present in pregnancies with no risk factors?". Prenat Diagn (2013) 1.38
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain (2008) 1.37
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Mov Disord (2011) 1.25
Neural correlates of focused attention and cognitive monitoring in meditation. Brain Res Bull (2010) 1.24
Extensive host sharing of central European Tula virus. J Virol (2010) 1.18
Acute akinesia in Parkinson disease. Neurology (2005) 1.17
Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. Mov Disord (2005) 1.16
Yersinia pestis DNA from skeletal remains from the 6(th) century AD reveals insights into Justinianic Plague. PLoS Pathog (2013) 1.14
Ischemic preconditioning blocks BAD translocation, Bcl-xL cleavage, and large channel activity in mitochondria of postischemic hippocampal neurons. Proc Natl Acad Sci U S A (2008) 1.12
Differential patterns of cortical activation as a function of fluid reasoning complexity. Hum Brain Mapp (2009) 1.06
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain (2013) 1.05
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study. J Clin Psychopharmacol (2012) 1.04
Dopa-responsive pseudo-orthostatic tremor in parkinsonism. Mov Disord (2007) 1.02
Acute effects of modafinil on brain resting state networks in young healthy subjects. PLoS One (2013) 1.02
Temporal evolution of oscillatory activity predicts performance in a choice-reaction time reaching task. J Neurophysiol (2010) 1.01
Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Mov Disord (2007) 0.99
Neural systems underlying observation of humanly impossible movements: an FMRI study. Cereb Cortex (2005) 0.98
Visuo-attentional and sensorimotor alpha rhythms are related to visuo-motor performance in athletes. Hum Brain Mapp (2009) 0.98
Noxious somatosensory stimulation affects the default mode of brain function: evidence from functional MR imaging. Radiology (2009) 0.97
Functional topography of the secondary somatosensory cortex for nonpainful and painful stimuli: an fMRI study. Neuroimage (2003) 0.96
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients. Mov Disord (2011) 0.96
Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology (2010) 0.95
Magnetocardiography: current status and perspectives. Part II: Clinical applications. Ital Heart J (2002) 0.94
Functional topography of the secondary somatosensory cortex for nonpainful and painful stimulation of median and tibial nerve: an fMRI study. Neuroimage (2004) 0.93
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. Neuromuscul Disord (2008) 0.93
Extremely rare case of vascular dysphagia in an elderly man. Circulation (2013) 0.93
Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. Parkinsonism Relat Disord (2013) 0.93
The impact of visual impairment on Mini-Mental State Examination Scores in the Newcastle 85+ study. Age Ageing (2012) 0.92
Psychiatric issues in cognitive impairment. Mov Disord (2014) 0.91
Modulation of gamma and theta spectral amplitude and phase synchronization is associated with the development of visuo-motor learning. J Neurosci (2011) 0.91
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Mov Disord (2006) 0.90
Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert Rev Neurother (2013) 0.90
Behavioural and psychophysiological correlates of athletic performance: a test of the multi-action plan model. Appl Psychophysiol Biofeedback (2013) 0.90
Autoscopic phenomena: case report and review of literature. Behav Brain Funct (2011) 0.90
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment. Parkinsonism Relat Disord (2009) 0.88
Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics (2009) 0.88
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency. Brain Res (2012) 0.88
Modifications of default-mode network connectivity in patients with cerebral glioma. PLoS One (2012) 0.88
Assessment of cognitive fluctuation in dementia: a systematic review of the literature. Int J Geriatr Psychiatry (2012) 0.87
Human secondary somatosensory cortex is involved in the processing of somatosensory rare stimuli: an fMRI study. Neuroimage (2008) 0.87
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features. Neuropsychiatr Dis Treat (2008) 0.86
Sonographic assessment of a suspected biloma: A case report and review of the literature. World J Radiol (2013) 0.86
Modulation of MCP-1 and iNOS by 50-Hz sinusoidal electromagnetic field. Nitric Oxide (2006) 0.86
Cortical brain responses during passive nonpainful median nerve stimulation at low frequencies (0.5-4 Hz): an fMRI study. Hum Brain Mapp (2007) 0.86
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis. J Proteomics (2011) 0.86
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. J Neurol (2010) 0.85
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation. Neurol Sci (2013) 0.85
The assessment of cognition in visually impaired older adults. Age Ageing (2012) 0.85
Performance comparison of six independent components analysis algorithms for fetal signal extraction from real fMCG data. Phys Med Biol (2006) 0.85
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks. Parkinsonism Relat Disord (2009) 0.85
Data-driven grading of brain gliomas: a multiparametric MR imaging study. Radiology (2014) 0.84
MR angiography, MR imaging and proton MR spectroscopy in-vivo assessment of skeletal muscle ischemia in diabetic rats. PLoS One (2012) 0.84
Altered brain response without behavioral attention deficits in healthy siblings of schizophrenic patients: an event-related fMRI study. Neuroimage (2009) 0.84
HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease. Mov Disord (2003) 0.84
Striatal activity during intentional switching depends on pattern stability. J Neurosci (2010) 0.84
Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study. PLoS One (2013) 0.84
Effects of somatosensory stimulation and attention on human somatosensory cortex: an fMRI study. Neuroimage (2010) 0.84
An expert opinion on safinamide in Parkinson's disease. Expert Opin Investig Drugs (2008) 0.83
Task-specific lower lip dystonia due to mantra recitation. Mov Disord (2007) 0.83
Amantadine in the treatment of pathological gambling: a case report. Front Psychiatry (2012) 0.83
The role of left superior parietal lobe in male sexual behavior: dynamics of distinct components revealed by FMRI. J Sex Med (2012) 0.83
Competence, achievement goals, motivational climate, and pleasant psychobiosocial states in youth sport. J Sports Sci (2011) 0.82